Insights into FDA's controversial decision to approve a new Alzheimer's treatment drug
Health Affairs This Week - Un pódcast de Health Affairs - Viernes
Listen to Health Affairs' Rob Lott and Leslie Erdelack discuss the FDA's controversial decision to approve Aduhelm (aducanumab) to treat patients with Alzheimer's disease.
